California Public Employees Retirement System Nymox Pharmaceutical Corp Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$1.46 - $2.48 $116,508 - $197,904
-79,800 Closed
0 $0
Q4 2020

Feb 02, 2021
SELL
$1.84 - $2.83 $14,013 - $21,553
-7,616 Reduced 8.71%
79,800 $198,000
Q2 2020

Aug 12, 2020
BUY
$2.1 - $4.6 $141,153 - $309,193
67,216 Added 332.75%
87,416 $310,000
Q3 2017

Nov 15, 2017
BUY
$3.36 - $4.02 $67,872 - $81,203
20,200
20,200 $77,000

Others Institutions Holding NYMX

# of Institutions
6
Shares Held
150K
Call Options Held
0
Put Options Held
0
View Full List

About NYMOX PHARMACEUTICAL CORP

NYMX Quotes by TradingView
  • Ticker NYMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,265,000
  • Market Cap $42.9M
  • Description
  • Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...
More about NYMX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email